Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase

Marleen C D G Huigen, Loek de Graaf, Dirk Eggink, Rob Schuurman, V. Müller, Anna Stamp, David K. Stammers, Charles A B Boucher, Monique Nijhuis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

HIV-1 isolates harbouring an insertion in the β3-β4 loop of reverse transcriptase (RT) confer high-level resistance to nucleoside analogues. We have identified a novel 5-amino-acid insertion (KGSNR amino acids 66-70) in a patient on prolonged nucleoside combination therapy (didanosine and stavudine) and investigated which factors were responsible for its outgrowth. Remarkably, only small fold increases in drug resistance to nucleoside analogues were observed compared to wild type. The insertion variant displayed a reduced replicative capacity in the absence of inhibitor, but had a slight replicative advantage in the presence of zidovudine, didanosine or stavudine, resulting in the selection and persistence of this insertion in vivo. Mathematical analyses of longitudinal samples indicated a 2% in vivo fitness advantage for the insertion variant compared to the initial viral population. The novel RT insertion variant conferring low levels of resistance was able to evolve towards a high-level resistant replication-competent variant.

Original languageEnglish
Pages (from-to)395-406
Number of pages12
JournalVirology
Volume364
Issue number2
DOIs
Publication statusPublished - Aug 1 2007

Fingerprint

Nucleosides
Stavudine
Didanosine
RNA-Directed DNA Polymerase
Amino Acids
Zidovudine
Drug Resistance
HIV-1
Population
Human immunodeficiency virus 1 reverse transcriptase
Therapeutics

Keywords

  • HIV-1
  • Insertion
  • Replication capacity
  • Resistance
  • Reverse transcriptase

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Huigen, M. C. D. G., de Graaf, L., Eggink, D., Schuurman, R., Müller, V., Stamp, A., ... Nijhuis, M. (2007). Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase. Virology, 364(2), 395-406. https://doi.org/10.1016/j.virol.2007.03.028

Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase. / Huigen, Marleen C D G; de Graaf, Loek; Eggink, Dirk; Schuurman, Rob; Müller, V.; Stamp, Anna; Stammers, David K.; Boucher, Charles A B; Nijhuis, Monique.

In: Virology, Vol. 364, No. 2, 01.08.2007, p. 395-406.

Research output: Contribution to journalArticle

Huigen, MCDG, de Graaf, L, Eggink, D, Schuurman, R, Müller, V, Stamp, A, Stammers, DK, Boucher, CAB & Nijhuis, M 2007, 'Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase', Virology, vol. 364, no. 2, pp. 395-406. https://doi.org/10.1016/j.virol.2007.03.028
Huigen, Marleen C D G ; de Graaf, Loek ; Eggink, Dirk ; Schuurman, Rob ; Müller, V. ; Stamp, Anna ; Stammers, David K. ; Boucher, Charles A B ; Nijhuis, Monique. / Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase. In: Virology. 2007 ; Vol. 364, No. 2. pp. 395-406.
@article{867b6ea3743341ad8b566057c2acacf7,
title = "Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase",
abstract = "HIV-1 isolates harbouring an insertion in the β3-β4 loop of reverse transcriptase (RT) confer high-level resistance to nucleoside analogues. We have identified a novel 5-amino-acid insertion (KGSNR amino acids 66-70) in a patient on prolonged nucleoside combination therapy (didanosine and stavudine) and investigated which factors were responsible for its outgrowth. Remarkably, only small fold increases in drug resistance to nucleoside analogues were observed compared to wild type. The insertion variant displayed a reduced replicative capacity in the absence of inhibitor, but had a slight replicative advantage in the presence of zidovudine, didanosine or stavudine, resulting in the selection and persistence of this insertion in vivo. Mathematical analyses of longitudinal samples indicated a 2{\%} in vivo fitness advantage for the insertion variant compared to the initial viral population. The novel RT insertion variant conferring low levels of resistance was able to evolve towards a high-level resistant replication-competent variant.",
keywords = "HIV-1, Insertion, Replication capacity, Resistance, Reverse transcriptase",
author = "Huigen, {Marleen C D G} and {de Graaf}, Loek and Dirk Eggink and Rob Schuurman and V. M{\"u}ller and Anna Stamp and Stammers, {David K.} and Boucher, {Charles A B} and Monique Nijhuis",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.virol.2007.03.028",
language = "English",
volume = "364",
pages = "395--406",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Evolution of a novel 5-amino-acid insertion in the β3-β4 loop of HIV-1 reverse transcriptase

AU - Huigen, Marleen C D G

AU - de Graaf, Loek

AU - Eggink, Dirk

AU - Schuurman, Rob

AU - Müller, V.

AU - Stamp, Anna

AU - Stammers, David K.

AU - Boucher, Charles A B

AU - Nijhuis, Monique

PY - 2007/8/1

Y1 - 2007/8/1

N2 - HIV-1 isolates harbouring an insertion in the β3-β4 loop of reverse transcriptase (RT) confer high-level resistance to nucleoside analogues. We have identified a novel 5-amino-acid insertion (KGSNR amino acids 66-70) in a patient on prolonged nucleoside combination therapy (didanosine and stavudine) and investigated which factors were responsible for its outgrowth. Remarkably, only small fold increases in drug resistance to nucleoside analogues were observed compared to wild type. The insertion variant displayed a reduced replicative capacity in the absence of inhibitor, but had a slight replicative advantage in the presence of zidovudine, didanosine or stavudine, resulting in the selection and persistence of this insertion in vivo. Mathematical analyses of longitudinal samples indicated a 2% in vivo fitness advantage for the insertion variant compared to the initial viral population. The novel RT insertion variant conferring low levels of resistance was able to evolve towards a high-level resistant replication-competent variant.

AB - HIV-1 isolates harbouring an insertion in the β3-β4 loop of reverse transcriptase (RT) confer high-level resistance to nucleoside analogues. We have identified a novel 5-amino-acid insertion (KGSNR amino acids 66-70) in a patient on prolonged nucleoside combination therapy (didanosine and stavudine) and investigated which factors were responsible for its outgrowth. Remarkably, only small fold increases in drug resistance to nucleoside analogues were observed compared to wild type. The insertion variant displayed a reduced replicative capacity in the absence of inhibitor, but had a slight replicative advantage in the presence of zidovudine, didanosine or stavudine, resulting in the selection and persistence of this insertion in vivo. Mathematical analyses of longitudinal samples indicated a 2% in vivo fitness advantage for the insertion variant compared to the initial viral population. The novel RT insertion variant conferring low levels of resistance was able to evolve towards a high-level resistant replication-competent variant.

KW - HIV-1

KW - Insertion

KW - Replication capacity

KW - Resistance

KW - Reverse transcriptase

UR - http://www.scopus.com/inward/record.url?scp=34249878759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249878759&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2007.03.028

DO - 10.1016/j.virol.2007.03.028

M3 - Article

VL - 364

SP - 395

EP - 406

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -